Abstract
A thorough understanding of the cognitive effects of antidepressant medications is essential given their frequency of use. This meta-analysis was conducted to investigate whether antidepressants differentially affect the various domains of cognitive functioning for depressed and non-depressed participants. An electronic search of PsycInfo, Medline and Google Scholar was conducted for all journal articles published between January 1998 and January 2017. Thirty-three studies were included enabling calculation of Hedges’ g using a random effects model for the cognitive domains of divided attention, executive function, expressive language, immediate memory, perceptual motor skills, processing speed, recent memory, sustained attention, visuospatial-constructional skills and working memory. Results revealed that overall, antidepressants have a modest, positive effect on divided attention, executive function, immediate memory, processing speed, recent memory and sustained attention for depressed participants. Selective serotonin reuptake inhibitors (SSRI’s) were found to have the greatest positive effect on cognition for depressed participants, as compared to the other classes of antidepressants analysed. Antidepressants did not significantly affect cognitive function in non-depressed participants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Airaksinen, E., Larsson, M., Lundberg, I., & Forsell, Y. (2004). Cognitive functions in depressive disorders: evidence from a population-based study. Psychological Medicine, 34, 83–91. https://doi.org/10.1017/S0033291703008559.
Amado-Boccara, I., Gougoulis, N., Littre, M. P., Galinowski, A., & Loo, H. (1995). Effects of antidepressants on cognitive functions: A review. Neuroscience & Biobehavioral Reviews, 19, 479–493. https://doi.org/10.1016/0149-7634(94)00068-C.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington: American Psychiatric Publishing.
Anderson, I. M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58, 19–36. https://doi.org/10.1016/S0165-0327(99)00092-0.
Anderson, I., Nutt, D., & Deakin, J. (2000). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 14, 3–20. https://doi.org/10.1177/026988110001400101.
Andrade, C., & Rao, N. S. K. (2010). How antidepressant drugs act: a primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian Journal of Psychiatry, 52, 378–396. https://doi.org/10.4103/0019-5545.74318.
Artigas, F. (2013). Serotonin receptors involved in antidepressant effects. Pharmacology & Therapeutics, 137, 119–131. https://doi.org/10.1016/j.pharmthera.2012.09.006.
Ashare, R. L., & McKee, S. A. (2012). Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Experimental and Clinical Psychopharmacology, 20, 63–70. https://doi.org/10.1037/a0025594.
Austin, M.-P., Mitchell, P., & Goodwin, G. M. (2001). Cognitive deficits in depression. The British Journal of Psychiatry, 178, 200–206.
Australian Bureau of Statistics (ABS) (2016). Patterns of Use of Mental Health Services and Prescription Medications, 2011. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4329.0.00.003~2011~Main%20Features~Antidepressants~10008 (accessed 4 February 2017).
Australian Institute of Health and Welfare (AIHW) (2016). Australia’s Health 2016. http://www.aihw.gov.au/australias-health/2016/ (accessed 4 February 2017).
Banos, J. H., Novack, T. A., Brunner, R., Renfroe, S., Lin, H. Y., & Meythaler, J. (2010). Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury. Journal of Head Trauma Rehabilitation, 25, 357–361.
Barch, D. M., Sheline, Y. I., Csernansky, J. G., & Snyder, A. Z. (2003). Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biological Psychiatry, 53, 376–384. https://doi.org/10.1097/HTR.0b013e3181d6c715.
Baune, B. T., & Renger, L. (2014). Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression-A systematic review. Psychiatry Research, 219, 25–50. https://doi.org/10.1016/j.psychres.2014.05.013.
Bech, P., Cialdella, P., Haugh, M., Hours, A., Boissel, J., Birkett, M., & Tollefson, G. (2000). Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. The British Journal of Psychiatry, 176, 421–428.
Bench, C., Frith, C. D., Grasby, P. M., Friston, K. J., Paulesu, E., Frackowiak, R. S. J., & Dolan, R. J. (1993). Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia, 31, 907–922. https://doi.org/10.1016/0028-3932(93)90147-R.
Benedict, R. H., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test–Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43–55.
Benton, A. L., de Hamsher, K. S., & Sivan, A. B. (1994). Multilingual aphasia examination (3rd ed.). Lutz: Psychological Assessment Resources (PAR).
Biringer, E., Rongve, A., & Lund, A. (2009). A review of modern antidepressants' effects on neurocognitive function. Current Psychiatry Reviews, 5, 164–174.
Boggio, P. S., Fregni, F., Bermpohl, F., Mansur, C. G., Rosa, M., Rumi, D. O., et al. (2005). Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Movement Disorders, 20, 1178–1184. https://doi.org/10.1002/mds.20508.
Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2009). Introduction to Meta-Analysis. West Sussex: Wiley.
Borenstein, M., Hedges, L. V., Higgins, J., & Rothstein, H. R. (2010). A basic introduction to fixed-effect and random-effects models for meta-nalysis. Research Synthesis Methods, 1, 97–111. https://doi.org/10.1002/jrsm.12.
Brooks, J. O., & Hoblyn, J. C. (2007). Neurocognitive costs and benefits of psychotropic medications in older adults. Journal of Geriatric Psychiatry and Neurology, 20, 199–214. https://doi.org/10.1177/0891988707308803.
Buist-Bouwman, M., Ormel, J., De Graaf, R., De Jonge, P., Van Sonderen, E., Alonso, J., et al. (2008). Mediators of the association between depression and role functioning. Acta Psychiatrica Scandinavica, 118, 451–458. https://doi.org/10.1111/j.1600-0447.2008.01285.x.
Buschke, H., & Fuld, P. A. (1974). Evaluation of storage, retention and retrieval in disordered memory and learning. Neurology, 11, 1019–1025. https://doi.org/10.1212/WNL.24.11.1019.
Butters, M. A., Becker, J. T., Nebes, R. D., Zmuda, M. D., Mulsant, B. H., Pollock, B. G., & Reynolds III, C. F. (2000). Changes in cognitive functioning following treatment of late-life depression. American Journal of Psychiatry, 157, 1949–1954. https://doi.org/10.1176/appi.ajp.157.12.1949.
Butters, M. A., Young, J. B., Lopez, O., Aizenstein, H. J., Mulsant, B. H., Reynolds III, C. F., et al. (2008). Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues in Clinical Neuroscience, 10, 345–357.
Cameron, C., Fireman, B., Hutton, B., Clifford, T., Coyle, D., Wells, G., et al. (2015). Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities. Systematic Reviews, 4, 147–155. https://doi.org/10.1186/s13643-015-0133-0.
Channon, S. (1996). Executive dysfunction in depression: the Wisconsin card sorting test. Journal of Affective Disorders, 39, 107–114. https://doi.org/10.1016/0165-0327(96)00027-4.
Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13, 181–197.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates.
Conners, C. K. (2000). Conner’s Continuous Performance Test (CPT II) computer programs for Windows: Technical manual and software guide (Ver. 5). North Tonawanda: Multi-Health Systems, Inc..
Connolly, K. R., & Thase, M. E. (2012). Emerging drugs for major depressive disorder. Expert Opinion on Emerging Drugs, 17, 105–126.
Crowe, S. (2010). Evidence of absence: A guide to cognitive assessment in Australia. Bowen Hills: Australian Academic Press.
Culang, M. E., Sneed, J. R., Keilp, J. G., Rutherford, B. R., Pelton, G. H., Devanand, D., & Roose, S. P. (2009). Change in cognitive functioning following acute antidepressant treatment in late-life depression. The American Journal of Geriatric Psychiatry, 17, 881–888. https://doi.org/10.1097/JGP.0b013e3181b4bf4a.
Culang-Reinlieb, M. E., Sneed, J. R., Keilp, J. G., & Roose, S. P. (2012). Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. International Journal of Geriatric Psychiatry, 27, 777–784. https://doi.org/10.1002/gps.2783.
Daffner, K. R., Gale, S. A., Barrett, A., Boeve, B. F., Chatterjee, A., Coslett, H. B., et al. (2015). Improving clinical cognitive testing Report of the AAN Behavioral Neurology Section Workgroup. Neurology, 85, 910–918.
Danion, J. (1993). Antidepressive agents and memory. L'Encephale, 19, 417–422.
Deakin, J., Rahman, S., Nestor, P., Hodges, J., & Sahakian, B. (2004). Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology, 172, 400–408. https://doi.org/10.1007/s00213-003-1686-5.
Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2000). California Verbal Learning Test-Second Edition (CVLT-II). San Antonio: Psychological Corporation.
Desrosiers, J., Hebert, R., Bravo, G., & Dutil, E. (1995). The Purdue Pegboard Test: normative data for people aged 60 and over. Disability and Rehabilitation, 17, 217–224. https://doi.org/10.3109/09638289509166638.
Devanand, D., Pelton, G. H., Marston, K., Camacho, Y., Roose, S. P., Stern, Y., & Sackeim, H. A. (2003). Sertraline treatment of elderly patients with depression and cognitive impairment. International Journal of Geriatric Psychiatry, 18, 123–130. https://doi.org/10.1002/gps.802.
Dickinson, D., Ramsey, M. E., & Gold, J. M. (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64, 532–542. https://doi.org/10.1001/archpsyc.64.5.532.
Doraiswamy, P., Krishnan, K., Oxman, T., Jenkyn, L. R., Coffey, D. J., Burt, T., & Clary, C. M. (2003). Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients? The Journals of Gerontology: Series A: Biological Sciences and Medical Sciences, 58A, 1137–1144. https://doi.org/10.1093/gerona/58.12.M1137.
Downes, J. J., Roberts, A. C., Sahakian, B. J., Evenden, J. L., Robbins, R. G., & Robbins, T. W. (1989). Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: evidence for a specific attentional dysfunction. Neuropsychologia, 27, 1329–1343. https://doi.org/10.1016/0028-3932(89)90128-0.
Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors
Elias, A., Laurencic, G., & Malone, D. (2006). Side effects of antidepressants: an overview. Cleveland Clinic Journal of Medicine, 73, 351–361.
Faber, T., Ravaud, P., Riveros, C., Perrodeau, E., & Dechartres, A. (2016). Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review. BMC Medical Research Methodology, 16, 35–60. https://doi.org/10.1186/s12874-016-0136-0.
Fani, N., Kitayama, N., Ashraf, A., Reed, L., Afzal, N., Jawed, F., & Bremner, J. D. (2009). Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacology Bulletin, 42, 53–68.
Fann, J. R., Uomoto, J. M., & Katon, W. J. (2001). Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics, 42, 48–54. https://doi.org/10.1176/appi.psy.42.1.48.
Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649–659. https://doi.org/10.1016/S0006-3223(03)00231-2.
Finkel, S. I., Richter, E. M., Clary, C. M., & Batzar, E. (1999). Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression. The American Journal of Geriatric Psychiatry, 7, 221–227. https://doi.org/10.1097/00019442-199908000-00006.
Follmann, D., Elliott, P., Suh, I., & Cutler, J. (1992). Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology, 45, 769–773. https://doi.org/10.1016/0895-4356(92)90054-Q.
Gallassi, R., Di Sarro, R., Morreale, A., & Amore, M. (2006). Memory impairment in patients with late-onset major depression: The effect of antidepressant therapy. Journal of Affective Disorders, 91, 243–250. https://doi.org/10.1016/j.jad.2006.01.018.
Gau, S. F., & Huang, W. L. (2014). Rapid visual information processing as a cognitive endophenotype of attention deficit hyperactivity disorder. Psychological Medicine, 44, 435–446. https://doi.org/10.1017/S0033291713000640.
Geake, J. G., & Hansen, P. C. (2010). Functional neural correlates of fluid and crystallized analogizing. NeuroImage, 49, 3489–3497. https://doi.org/10.1016/j.neuroimage.2009.09.008.
Goodwin, G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology, 11, 115–122. https://doi.org/10.1177/026988119701100204.
Grant, J. E., Chamberlain, S. R., Schreiber, L., & Odlaug, B. L. (2012). Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence, 121, 159–162. https://doi.org/10.1016/j.drugalcdep.2011.08.015.
Greer, T. L., Sunderajan, P., Grannemann, B. D., Kurian, B. T., & Trivedi, M. H. (2014). Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction? Depression Research and Rreatment, 1–14: doi:https://doi.org/10.1155/2014/627863
Harmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009). Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. The British Journal of Psychiatry, 195, 102–108. https://doi.org/10.1192/bjp.bp.108.051193.
Harrison, J. E., Lam, R. W., Baune, B. T., & McIntyre, R. S. (2016). Selection of cognitive tests for trials of therapeutic agents. The Lancet Psychiatry, 3, 499. https://doi.org/10.1016/S2215-0366(16)30067-0.
Harvey, S. T., & Taylor, J. E. (2010). A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents. Clinical Psychology Review, 30, 517–535. https://doi.org/10.1016/j.cpr.2010.03.006.
Harvey, P., Le Bastard, G., Pochon, J., Levy, R., Allilaire, J., Dubois, B. e., et al. (2004). Executive functions and updating of the contents of working memory in unipolar depression. Journal of Psychiatric Research, 38, 567–576. https://doi.org/10.1016/j.jpsychires.2004.03.003.
Herrera-Guzman, I., Herrera-Abarca, J. E., Gudayol-Ferre, E., Herrera-Guzman, D., Gomez-Carbajal, L., Pena-Olvira, M., et al. (2010). Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatry Research, 177, 323–329. https://doi.org/10.1016/j.psychres.2010.03.006.
Higgin, J., Thompson, S., Deeks, J., & Altman, D. (2003). Measuring inconsistency in meta-analysis. British Medical Journal, 327, 557–560. https://doi.org/10.1136/bmj.327.7414.557.
Higgins, J., & Green, S. (Editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hooper, H. E. (1983). Hooper Visual Organization Test Manual. Los Angeles: Western Psychological Services.
Horsfield, S. A., Rosse, R. B., Tomasino, V., Schwartz, B. L., Mastropaolo, J., & Deutsch, S. I. (2002). Fluoxetine's effects on cognitive performance in patients with traumatic brain injury. The International Journal of Psychiatry in Medicine, 32, 337–344. https://doi.org/10.2190/KQ48-XT0L-2H14-5UMV.
Horst, W. D., & Preskorn, S. H. (1998). Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of Affective Disorders, 51, 237–254.
Hoyer, W. J., Stawski, R. S., Wasylyshyn, C., & Verhaeghen, P. (2004). Adult age and digit symbol substitution performance: a meta-analysis. Psychology and Aging, 19, 211–214. https://doi.org/10.1037/0882-7974.19.1.211.
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006). Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research, 145, 39–48. https://doi.org/10.1016/S0165-0327(98)00222-5.
Jorge, R. E., Acion, L., Moser, D., Adams Jr., H. P., & Robinson, R. G. (2010). Escitalopram and enhancement of cognitive recovery following stroke. Archives of General Psychiatry, 67, 187–196. https://doi.org/10.1001/archgenpsychiatry.2009.185.
Joy, S., Kaplan, E., & Fein, D. (2004). Speed and memory in the WAIS-III Digit Symbol— Coding subtest across the adult lifespan. Archives of Clinical Neuropsychology, 19, 759–767. https://doi.org/10.1016/j.acn.2003.09.009.
Kalechstein, A., Mahoney, J., Yoon, J., Bennett, R., & De la Garza, R. (2013). Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users. Neuropharmacology, 64, 472–478. https://doi.org/10.1016/j.neuropharm.2012.06.064.
Karsten, J., Hagenauw, L. A., Kamphuis, J., & Lancel, M. (2017). Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial. Journal of Psychopharmacology, 31, 327–337. https://doi.org/10.1177/0269881116681399.
Katona, C., Hansen, T., & Olsen, C. K. (2012). A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. International Clinical Psychopharmacology, 27, 215–223. https://doi.org/10.1097/YIC.0b013e3283542457.
Keefe, R., McClintock, S. M., Roth, R. M., Doraiswamy, P. M., Tiger, S., & Madhoo, M. (2014). Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. Journal of Clinical Psychiatry, 75, 864–876. https://doi.org/10.4088/JCP.13r08609.
Kertesz, A. (2007). Western Aphasia Battery Revised. Examiner’s Manual. San Antonio: Pearson.
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, e45. https://doi.org/10.1371/journal.pmed.0050045.
Knegtering, H., Eijck, M., & Huijsman, A. (1994). Effects of antidepressants on cognitive functioning of elderly patients. Drugs & Aging, 5, 192–199. https://doi.org/10.2165/00002512-199405030-00005.
Krikorian, R., Bartok, J., & Gay, N. (1994). Tower of London procedure: a standard method and developmental data. Journal of Clinical and Experimental Neuropsychology, 16, 840–850. https://doi.org/10.1080/01688639408402697.
Lambert, O., & Bourin, M. (2002). SNRIs: mechanism of action and clinical features. Expert Review of Neurotherapeutics, 2, 849–858. https://doi.org/10.1586/14737175.2.6.849.
Lau, J., Ioannidis, J. P., & Schmid, C. H. (1998). Summing up evidence: one answer is not always enough. The Lancet, 351, 123–127. https://doi.org/10.1016/S0140-6736(97)08468-7.
Lee, H., Kim, S. W., Kim, J. M., Shin, I. S., Yang, S. J., & Yoon, J. S. (2005). Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Human Psychopharmacology, 20, 97–104. https://doi.org/10.1002/hup.668.
Levaux, M. N., Potvin, S., Sepehry, A. A., Sablier, J., Mendrek, A., & Stip, E. (2007). Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. European Psychiatry, 22, 104–115. https://doi.org/10.1016/j.eurpsy.2006.11.004.
Levkovitz, Y., Caftori, R., Avital, A., & Richter-Levin, G. (2002). The SSRI's drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression. Brain Research Bulletin, 58, 345–350. https://doi.org/10.1016/S0361-9230(01)00780-8.
Lezak, M., Howieson, D., Bigler, E., & Tranel, D. (2012). Neuropsychological Assessment (5th ed.). New York: Oxford University Press.
Liotti, M., & Mayberg, H. S. (2001). The role of functional neuroimaging in the neuropsychology of depression. Journal of Clinical and Experimental Neuropsychology, 23, 121–136.
Livingston, M. G., & Livingston, H. M. (1996). Monoamine oxidase inhibitors. Drug Safety, 14, 219–227. https://doi.org/10.2165/00002018-199614040-00002.
Lochner, C., Chamberlain, S. R., Kidd, M., Fineberg, N. A., & Stein, D. J. (2016). Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder. Psychopharmacology, 233, 883–891. https://doi.org/10.1007/s00213-015-4172-y.
Loubinoux, I., Tombari, D., Pariente, J., Gerdelat-Mas, A., Franceries, X., Cassol, E., et al. (2005). Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. NeuroImage, 27, 299–313. https://doi.org/10.1016/j.neuroimage.2004.12.023.
MacGillivray, S., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., et al. (2003). Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. British Medical Journal, 326, 1–6. https://doi.org/10.1136/bmj.326.7397.1014.
Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015). A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology, 40, 2025–2037. https://doi.org/10.1038/npp.2015.52.
Manes, F., Sahakian, B., Clark, L., Rogers, R., Antoun, N., Aitken, M., & Robbins, T. (2002). Decision-making processes following damage to the prefrontal cortex. Brain, 125, 624–639. https://doi.org/10.1093/brain.
Marson, D. C., Dymek, M. P., Duke, L. W., & Harrell, L. E. (1997). Subscale validity of the Mattis Dementia Rating Scale. Archives of Clinical Neuropsychology, 12, 269–275. https://doi.org/10.1093/arclin/12.3.269.
McCall, W. V., & Dunn, A. G. (2003). Cognitive deficits are associated with functional impairment in severely depressed patients. Psychiatry Research, 121, 179–184. https://doi.org/10.1016/j.psychres.2003.09.003.
McClintock, S. M., Husain, M. M., Greer, T. L., & Cullum, C. M. (2010). Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology, 24, 9–34. https://doi.org/10.1037/a0017336.
McDermott, L. M., & Ebmeier, K. P. (2009). A meta-analysis of depression severity and cognitive function. Journal of Affective Disorders, 119, 1–8. https://doi.org/10.1016/j.jad.2009.04.022.
McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., et al. (2013). Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depression and Anxiety, 30, 515–527. https://doi.org/10.1002/da.22063.
McIntyre, R. S., Lophaven, S., & Olsen, C. K. (2014). A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. International Journal of Neuropsychopharmacology, 17, 1557–1567. https://doi.org/10.1017/S1461145714000546.
McKenna, P. (1998). The Category Specific Names Test. Levittown: Psychology Press.
Minshew, N. J., Goldstein, G., & Siegel, D. J. (1995). Speech and language in high-functioning autistic individuals. Neuropsychology, 9, 255–261. https://doi.org/10.1037/0894-4105.9.2.255.
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent variable analysis. Cognitive Psychology, 41, 49–100. https://doi.org/10.1006/cogp.1999.0734.
Mohs, R., Mease, P., Arnold, L. M., Wang, F., Ahl, J., Gaynor, P. J., & Wohlreich, M. M. (2012). The effect of duloxetine treatment on cognition in patients with fibromyalgia. Psychosomatic Medicine, 74, 628–634. https://doi.org/10.1097/PSY.0b013e31825b9855.
Moncrieff, J., Wessely, S., & Hardy, R. (2004). Active placebos versus antidepressants for depression. The Cochrane Library, 1. https://doi.org/10.1002/14651858.CD003012.pub2.
Morere, D. A., Witkin, G., & Murphy, L. (2012). Measures of expressive language. In Assessing Literacy in Deaf Individuals (pp. 141–157). Springer New York.
Mowla, A., Mosavinasab, M., Haghshenas, H., & Haghighi, A. B. (2007a). Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial. Journal of Clinical Psychopharmacology, 27, 484–487. https://doi.org/10.1097/jcp.0b013e31814b98c1.
Mowla, A., Mosavinasab, M., & Pani, A. (2007b). Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment?: a double-blind, placebo-controlled, clinical trial. Journal of Clinical Psychopharmacology, 27, 67–70. https://doi.org/10.1097/JCP.0b013e31802e0002.
Munro, C. A., Brandt, J., Sheppard, J.-M. E., Steele, C. D., Samus, Q. M., Steinberg, M., et al. (2004). Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS). The American Journal of Geriatric Psychiatry, 12, 491–498. https://doi.org/10.1097/00019442-200409000-00007.
Murphy, C. F., & Alexopoulos, G. S. (2004). Longitudinal association of initiation/perseveration and severity of geriatric depression. The American Journal of Geriatric Psychiatry, 12, 50–56. https://doi.org/10.1097/00019442-200401000-00007.
Naismith, S. L., Longley, W. A., Scott, E. M., & Hickie, I. B. (2007). Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry, 7, 32–39. https://doi.org/10.1186/1471-244X-7-32.
Nassir Ghaemi, S. (2008). Why antidepressants are not antidepressants: STEP-BD, STAR* D, and the return of neurotic depression. Bipolar Disorders, 10, 957–968. https://doi.org/10.1111/j.1399-5618.2008.00639.x.
Nebes, R. D., Butters, M., Mulsant, B., Pollock, B., Zmuda, M., Houck, P., & Reynolds, C. (2000). Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychological Medicine, 30, 679–691.
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., et al. (2003). Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology, 23, 155–168.
Nielen, M., & Den Boer, J. (2003). Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Psychological Medicine, 33, 917–925. https://doi.org/10.1017/S0033291703007682.
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2015). Faster, better, stronger: towards new antidepressant therapeutic strategies. European Journal of Pharmacology, 753, 32–50. https://doi.org/10.1016/j.ejphar.2014.07.046.
Olfson, M., & Marcus, S. C. (2009). National patterns in antidepressant medication treatment. Archives of General Psychiatry, 66, 848–856. https://doi.org/10.1001/archgenpsychiatry.2009.81.
Owen, A. M., Sahakian, B. J., Semple, J., Polkey, C. E., & Robbins, T. W. (1995). Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia, 33, 1–24. https://doi.org/10.1016/0028-3932(94)00098-A.
Owen, A. M., McMillan, K. M., Laird, A. R., & Bullmore, E. (2005). N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Human Brain Mapping, 25, 46–59. https://doi.org/10.1002/hbm.20131.
Oxman, T. E. (1996). Antidepressants and cognitive impairment in the elderly. The Journal of Clinical Psychiatry, 57, 38–44.
Paelecke-Habermann, Y., Pohl, J., & Leplow, B. (2005). Attention and executive functions in remitted major depression patients. Journal of Affective Disorders, 89, 125–135. https://doi.org/10.1016/j.jad.2005.09.006.
Paradiso, S., Lamberty, G. J., Garvey, M. J., & Robinson, R. G. (1997). Cognitive impairment in the euthymic phase of chronic unipolar depression. The Journal of Nervous and Mental disease, 185, 748–754.
Paterniti, S., Dufouil, C., Bisserbe, J. C., & Alperovitch, A. (1999). Anxiety, depression, psychotropic drug use and cognitive impairment. Psychological Medicine, 29, 421–428.
Patten, S. B., Esposito, E., & Carter, B. (2007). Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiology and Drug Safety, 16, 746–752. https://doi.org/10.1002/pds.1385.
PBS Expenditure and Prescriptions Report 2015 - 16 (2016). PBS Management Section Pharmaceutical Policy Branch. https://www.pbs.gov.au/info/browse/statistics (accessed 3 February 2017).
Pehrson, A. L., Leiser, S. C., Gulinello, M., Dale, E., Li, Y., Waller, J. A., & Sanchez, C. (2015). Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. European Journal of Pharmacology, 753, 19–31.
Peinemann, F., Tushabe, D. A., & Kleijnen, J. (2013). Using multiple types of studies in systematic reviews of health care interventions–a systematic review. PLoS One, 8, e85035. https://doi.org/10.1371/journal.pone.0085035.
Penn, E., & Tracy, D. K. (2012). The drugs don’t work? Antidepressants and the current and future pharmacological management of depression. Therapeutic Advances in Psychopharmacology, 2, 179–188. https://doi.org/10.1177/2045125312445469.
Peretti, S., Judge, R., & Hindmarch, I. (2000). Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica, 101, 17–25. https://doi.org/10.1111/j.1600-0447.2000.tb10944.x.
Petkova, E., Tarpey, T., Huang, L., & Deng, L. (2013). Interpreting meta-regression: application to recent controversies in antidepressants’ efficacy. Statistics in Medicine, 32, 2875–2892. https://doi.org/10.1002/sim.5766.
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003). Neurocognitive impairment in drug-free patients with major depressive disorder. The British Journal of Psychiatry, 182, 214–220. https://doi.org/10.1192/bjp.182.3.214.
PsychCorp. (2008). WAIS IV. Technical and interpretive manual. San Antonio: Pearson.
PsychCorp. (2009). Wechsler Memory Scale – Fourth Edition (WMS-IV) technical and interpretive manual. San Antonio: Pearson.
Randolph, C. (1998). RBANS Manual: Repeatable battery for the assessment of neurological status. San Antonio: Psychological Corporation.
Raskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., et al. (2007). Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial. The American Journal of Psychiatry, 164, 900–909.
Reitan, R. M., & Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Batter: Theory and clinical applications (2nd ed.). Tucson: Neuropsychology Press.
Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2009). Antidepressants for neuroenhancement in healthy individuals: a systematic review. Poiesis & Praxis, 6, 139–174. https://doi.org/10.1007/s10202-008-0060-4.
Rock, P., Roiser, J., Riedel, W., & Blackwell, A. (2014). Cognitive impairment in depression: a systematic review and meta-analysis. Psychological Medicine, 44, 2029. https://doi.org/10.1017/S0033291713002535.
Rose, E., & Ebmeier, K. (2006). Pattern of impaired working memory during major depression. Journal of Affective Disorders, 90, 149–161. https://doi.org/10.1016/j.jad.2005.11.003.
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2015). The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. International Journal of Neuropsychopharmacology, 1–13. DOI:https://doi.org/10.1093/ijnp/pyv082
Salthouse, T. A. (2000). Aging and measures of processing speed. Biological Psychology, 54, 35–54. https://doi.org/10.1016/S0301-0511(00)00052-1.
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805–809. https://doi.org/10.1126/science.1083328.
Sarapas, C., Shankman, S. A., Harrow, M., & Goldberg, J. F. (2012). Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study. Journal of Abnormal Psychology, 121, 830. https://doi.org/10.1037/a0028141.
Schmidt, M. (1996). Rey auditory verbal learning test: A handbook. Los Angeles: Western Psychological Services.
Schmitt, J. A., Ramaekers, J. G., Kruizinga, M. J., van Boxtel, M. P., Vuurman, E. F., & Riedel, W. J. (2002). Additional dopamine reuptake inhibition attenuates vigilance impairment by serotonin reutake inhibition in man. Journal of Psychopharmacology, 16, 207–214. https://doi.org/10.1177/026988110201600303.
Sheline, Y. I., Barch, D. M., Garcia, K., Gersing, K., Pieper, C., Welsh-Bohmer, K., et al. (2006). Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biological Psychiatry, 60, 58–65. https://doi.org/10.1016/j.biopsych.2005.09.019.
Shelton, R. C. (2000). Cellular mechanisms in the vulnerability to depression and response to antidepressants. Psychiatric Clinics of North America, 23, 713–729. https://doi.org/10.1016/S0193-953X(05)70193-3.
Shih, J., Chen, K., & Ridd, M. (1999). Monoamine oxidase: from genes to behavior. Annual Review of Neuroscience, 22, 197–217. https://doi.org/10.1146/annurev.neuro.22.1.197.
Shrier, I., Boivin, J.-F., Steele, R. J., Platt, R. W., Furlan, A., Kakuma, R., et al. (2007). Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. American Journal of Epidemiology, 166, 1203–1209. https://doi.org/10.1093/aje/kwm189.
Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., Wang, P., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert Opinion on Drug Safety, 2, 367–383. https://doi.org/10.1517/14740338.2.4.367.
Sriganesh, K., Shanthanna, H., & Busse, J. W. (2016). A brief overview of systematic reviews and meta-analyses. Indian Journal of Anaesthesia, 60, 689. https://doi.org/10.4103/0019-5049.190628.
Stein, R. A., & Strickland, T. L. (1998). A review of the neuropsychological effects of commonly used prescription medications. Archives of Clinical Neuropsychology, 13, 259–284. https://doi.org/10.1016/S0887-6177(97)00027-9.
Strauss, E., Sherman, E. M., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary. American Chemical Society.
Sweeney, J. A., Kmiec, J. A., & Kupfer, D. J. (2000). Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biological Psychiatry, 48, 674–684. https://doi.org/10.1016/S0006-3223(00)00910-0.
Talarowska, M., Florkowski, A., Zboralski, K., Berent, D., Wierzbiński, P., & Gałecki, P. (2010). Auditory-verbal declarative and operating memory among patients suffering from depressive disorders–preliminary study. Advances in Medical Sciences, 55, 317–327. https://doi.org/10.2478/v10039-010-0053-0.
Tendal, B., Higgins, J. P., Jüni, P., Hróbjartsson, A., Trelle, S., Nüesch, E., et al. (2009). Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ, 339, b3128. https://doi.org/10.1136/bmj.b3128.
Tipton, K. F., Boyce, S., O'Sullivan, J., Davey, G. P., & Healy, J. (2004). Monoamine oxidases: certainties and uncertainties. Current Medicinal Chemistry, 11, 1965–1982. https://doi.org/10.2174/0929867043364810.
Vythilingam, M., Vermetten, E., Anderson, G. M., Luckenbaugh, D., Anderson, E. R., Snow, J., et al. (2004). Hippocampal Volume, Memory, and Cortisol Status in Major Depressive Disorder: Effects of Treatment. Biological Psychiatry, 56, 101–112. https://doi.org/10.1016/j.biopsych.2004.04.002.
Wadsworth, E. J., Moss, S. C., Simpson, S. A., & Smith, A. P. (2005). SSRIs and cognitive performance in a working sample. Human Psychopharmacology: Clinical and Experimental, 20, 561–572. https://doi.org/10.1002/hup.725.
Walsh, N. D., Williams, S. C., Brammer, M. J., Bullmore, E. T., Kim, J., Suckling, J., et al. (2007). A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biological Psychiatry, 62, 1236–1243. https://doi.org/10.1016/j.biopsych.2006.12.022.
Wang, S., & Blazer, D. G. (2015). Depression and cognition in the elderly. Annual Review of Clinical Psychology, 11, 331–360. https://doi.org/10.1146/annurev-clinpsy-032814-112828.
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000). A systematic review of newer pharmacotherapies for depression in adults: evidence report summary: clinical guideline, part 2. Annals of Internal Medicine, 132, 743–756. https://doi.org/10.7326/0003-4819-132-9-200005020-00011.
Wills, P., Clare, L., Wills, P., Shiel, A., & Wilson, B. A. (2000). Assessing subtle memory impairments in the everyday memory performance of brain injured people: exploring the potential of the Extended Rivermead Behavioural Memory Test. Brain Injury, 14, 693–704. https://doi.org/10.1080/026990500413713.
Wilson, B. A., Cockburn, J., & Baddeley, A. D. (1985). The Rivermead Behavioural Memory Test. Bury St. Edmunds: Thames Valley Test.
Wroolie, T. E., Williams, K. E., Keller, J., Zappert, L. N., Shelton, S. D., Kenna, H. A., et al. (2006). Mood and neuropsychological changes in women with midlife depression treated with escitalopram. Journal of Clinical Psychopharmacology, 26, 361–366. https://doi.org/10.1097/01.jcp.0000227699.26375.f8.
Yıldız, A., Gönül, A. S., & Tamam, L. (2002). Mechanism of actions of antidepressants: beyond the receptors. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology, 12, 194–200.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prado, C.E., Watt, S. & Crowe, S.F. A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol Rev 28, 32–72 (2018). https://doi.org/10.1007/s11065-018-9369-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-018-9369-5